<p>Concordance of plasma and tumor results for <i>RAS</i> and <i>BRAF</i> mutations.</p
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
<p>BRAF mutation concordance between primary and metastatic specimens using MS-PCR.</p
<p>Metastases/comorbidity = at time of diagnosis of metastatic disease. P-value = exact p-value by C...
An accurate blood-based RAS mutation assay to determine eligibility of metastatic colorectal cancer ...
Aim: To determine the concordance between plasma and tissue RAS mutation status in metastatic colore...
Aim: To determine the concordance between plasma and tissue RAS mutation status in metastatic colore...
Aim: To determine the concordance between plasma and tissue RAS mutation status in metastatic colore...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
<p>Detection of <i>BRAF<sup>V600E</sup></i> mutations in melanomas grouped by tumor content.</p
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
<p>BRAF mutation concordance between primary and metastatic specimens using MS-PCR.</p
<p>Metastases/comorbidity = at time of diagnosis of metastatic disease. P-value = exact p-value by C...
An accurate blood-based RAS mutation assay to determine eligibility of metastatic colorectal cancer ...
Aim: To determine the concordance between plasma and tissue RAS mutation status in metastatic colore...
Aim: To determine the concordance between plasma and tissue RAS mutation status in metastatic colore...
Aim: To determine the concordance between plasma and tissue RAS mutation status in metastatic colore...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
<p>Detection of <i>BRAF<sup>V600E</sup></i> mutations in melanomas grouped by tumor content.</p
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceCirculating tumor DNA is a promising non-invasive tool for cancer monitoring. ...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...
International audienceIn patients with metastatic colorectal cancer (mCRC), RAS and BRAF mutations a...